Arbeitsgemeinschaft |  | Association for |
> Annual Meeting > Annual Meetings - Übersicht > Annual Meeting 2005 > Präsentationen 2005
Präsentationen Annual Meeting 2005
Session I: Why do we need Phase I studies?
W. Seifert, Berlin
Is Phase I useful?Is-Phase-I-useful-Seifert.pdf (415 kB)
H. Fuder, Mulhouse
Healthy volunteers or patients as target population in Phase I trials?Healthy-volunteers-or-patients-Fuder.pdf (4 MB)
H. Caplain, Paris
When to stop dose escalation - MTD or MLD or ?Stop-dose-escalation-Caplain.pdf (1 MB)
Session II: Implications of the new EU-Directive on clinical trials
A. Patat, Paris
FranceEU-Directive-France-Patat.pdf (210 kB)
R. Frey, Wuppertal
GermanyEU-Directive-Germany-Frey.pdf (239 kB)
S. Warrington, London
United KingdomEU-Directive-UK-Warrington.pdf (442 kB)
J. van Gerven, Leiden
The NetherlandsEU-Directive-Netherlands-van-Gerven.pdf (887 kB)
C. Reh, Berlin
Central EuropeEU-Directive-Central-Europe-Reh.pdf (309 kB)
A. Patat, Paris
Comparison between European countriesComparisons-between-European-countries-Patat.pdf (438 kB)
Session III: Safety issues in Phase I studies
M. Sibille, Lyon
Is Phase I safe?Is-Phase-I-safe-Sibille.pdf (228 kB)
B. Reigner, Basel
First dose and dose escalationFirst-dose-and-escalation-Reigner.pdf (121 kB)
G. Sanderink, Paris
Allometric scaling
No presentation available
Session IV: New tools in early drug development
E. Fuseau, Aix-en-Provence
When and how does PK/PD modelling and simulation make sense in early developmentPKPD-in-early-development-Fuseau.pdf (478 kB)
K.L. Rost, Berlin
Informed consent process in pharmacogenomic studies (Germany, France, international view)
No presentation available
R. Myers, London
Imaging in early drug developmentPET-scan-Myers.pdf (4 MB)
B. Acres, Strasbourg
New compounds derived from research on proteomics
No presentation available
Workshops
H. Allain, Rennes
Pharmacogenomics and drug safetyPharmacogenomics-and-drug-safety-Allain.pdf (385 kB)
P. Maisonblanche, Paris
QTc: Predictability, Science, RegulationQTc-Maisonblanche.pdf (3 MB)
M. Buyse, Bruxelles
Phase I in OncologyPhase-I-in-oncology-Buyse.pdf (878 kB)
Seite aktualisiert am 14.05.2009
